
PFRMAT AL
TARGET T0121
AUTHOR 3654-9178-1524 
METHOD bioinbgu seqpmprf
MODEL  2
PARENT 1ag4
REMARK  b  bbbbb      b        bbbbbbb      b            b
REMARK  FGEFRLKLLPDQFEVLGELGYVGREVIFGIRPEDLYDAMFARVRVPGENL
REMARK                       |             ||             
REMARK  MSVCKGVSGNPAKGEVFLYKHVNFQGDSWKVTGNVYDFRSVSGLNDVVSS
REMARK     bbb        bbbbbb      bbbbb bbbbb            b
REMARK  bbbbbbbbbb   bbbbbbb   bbbbbbb          bbbbbb   b
REMARK  VRAVVEIVENLGSERIVHLRVGGVTFVGAFRSESRVREGVEVDVVFDMKK
REMARK  |                                                 
REMARK  VKVGPNTKAFIFKDDRFNGNFIRLEESSQVTDLTTRNLNDAISSIIVATF
REMARK  bbbb bbbbbbbbb       bbbbb bbb  hhhhhh   bbbbbbbbb
REMARK  b
REMARK  I
REMARK   
REMARK  E
REMARK   
REMARK TARGET  FROM-TO   FOLD       FROM-TO  ALIG No.
REMARK TALIGN SEQ 0    20 120  1AG4 - 0      0 100  1.0 1
F 260 M 1
G 261 S 2
E 262 V 3
F 263 C 4
R 264 K 5
L 265 G 6
K 266 V 7
L 267 S 8
L 268 G 9
P 269 N 10
D 270 P 11
Q 271 A 12
F 272 K 13
E 273 G 14
V 274 E 15
L 275 V 16
G 276 F 17
E 277 L 18
L 278 Y 19
G 279 K 20
Y 280 H 21
V 281 V 22
G 282 N 23
R 283 F 24
E 284 Q 25
V 285 G 26
I 286 D 27
F 287 S 28
G 288 W 29
I 289 K 30
R 290 V 31
P 291 T 32
E 292 G 33
D 293 N 34
L 294 V 35
Y 295 Y 36
D 296 D 37
A 297 F 38
M 298 R 39
F 299 S 40
A 300 V 41
R 301 S 42
V 302 G 43
R 303 L 44
V 304 N 45
P 305 D 46
G 306 V 47
E 307 V 48
N 308 S 49
L 309 S 50
V 310 V 51
R 311 K 52
A 312 V 53
V 313 G 54
V 314 P 55
E 315 N 56
I 316 T 57
V 317 K 58
E 318 A 59
N 319 F 60
L 320 I 61
G 321 F 62
S 322 K 63
E 323 D 64
R 324 D 65
I 325 R 66
V 326 F 67
H 327 N 68
L 328 G 69
R 329 N 70
V 330 F 71
G 331 I 72
G 332 R 73
V 333 L 74
T 334 E 75
F 335 E 76
V 336 S 77
G 337 S 78
A 338 Q 79
F 339 V 80
R 340 T 81
S 341 D 82
E 342 L 83
S 343 T 84
R 344 T 85
V 345 R 86
R 346 N 87
E 347 L 88
G 348 N 89
V 349 D 90
E 350 A 91
V 351 I 92
D 352 S 93
V 353 S 94
V 354 I 95
F 355 I 96
D 356 V 97
M 357 A 98
K 358 T 99
K 359 F 100
TER
END

